Stimulant laxatives — the kind found in products like Dulcolax (bisacodyl), Senokot (senna), and Ex-Lax — are the ones gastroenterologists most frequently warn can become habit-forming with regular use. These drugs work by irritating the nerve endings in the colon wall, forcing muscle contractions that push stool through. The problem is that over weeks and months of daily use, the colon’s natural nerve signaling can weaken, leaving a person increasingly dependent on the medication to have a bowel movement at all. For older adults with dementia, who may already struggle to communicate discomfort or manage their own toileting routines, this dependency can quietly spiral into a serious medical issue that caregivers don’t catch until the person can no longer go without the pill. Safer long-term alternatives exist, and most of them work by a completely different mechanism.
Osmotic laxatives like MiraLAX (polyethylene glycol) draw water into the bowel to soften stool without stimulating the nerves. Fiber supplements like psyllium husk add bulk. And for many older adults, simply adjusting fluid intake, movement, and meal timing resolves the problem without any medication. This article walks through why stimulant laxatives carry unique risks for people with cognitive decline, what the medical evidence actually says about “dependency,” which alternatives work best for different situations, and how caregivers can build a bowel routine that reduces the need for laxatives altogether. The stakes are higher than most people realize. Chronic constipation in dementia patients is associated with increased agitation, confusion, urinary retention, and even hospitalizations — yet the reflexive solution of reaching for a stimulant laxative can make the underlying problem worse over time.
Table of Contents
- Why Do Doctors Say Stimulant Laxatives Are Habit-Forming?
- How Constipation Affects the Brain in Dementia Patients
- What Caregivers Should Use Instead — A Practical Breakdown
- Building a Bowel Routine That Reduces Laxative Dependence
- When Stimulant Laxatives Are Still the Right Call
- Medications That Make Constipation Worse in Dementia Patients
- Emerging Research on the Gut-Brain Connection and Constipation in Dementia
- Conclusion
- Frequently Asked Questions
Why Do Doctors Say Stimulant Laxatives Are Habit-Forming?
The term “habit-forming” in this context doesn’t mean addictive the way opioids are addictive. It means the body adapts. Stimulant laxatives like senna and bisacodyl work by activating neurons in the myenteric plexus — the network of nerves that controls gut motility. With repeated exposure, these nerve cells can become less responsive, a phenomenon sometimes called “cathartic colon.” The person needs higher doses to get the same effect, and without the drug, their colon barely moves at all. A 2019 review in the journal Neurogastroenterology & Motility confirmed that prolonged stimulant laxative use is associated with structural changes in the colonic nerve plexus, though researchers debate whether the laxatives cause the damage or whether people with already-damaged nerves are simply more likely to need laxatives. For someone with Alzheimer’s or another form of dementia, this distinction matters less than the practical reality.
Consider an 82-year-old woman whose caregiver gives her a senna tablet every evening because she hasn’t had a bowel movement that day. After three months, she can’t go without it. After six months, one tablet doesn’t work, so the caregiver doubles the dose. After a year, she’s having cramping, loose stools, and electrolyte imbalances that mimic a urinary tract infection — one of the most common triggers for acute delirium in dementia patients. Her doctor orders bloodwork and a hospital workup before anyone thinks to ask about her laxative regimen. The comparison worth understanding is this: stimulant laxatives force the colon to act, while osmotic laxatives and bulk-forming agents assist the colon in doing what it would normally do. The first approach carries real risks of physiological dependency. The second generally does not.
How Constipation Affects the Brain in Dementia Patients
Constipation is far more than a comfort issue for people with cognitive impairment. Research published in Alzheimer’s & Dementia in 2023 found that chronic constipation was independently associated with faster cognitive decline, even after adjusting for age, medications, and other health conditions. The proposed mechanisms include increased systemic inflammation from gut bacterial overgrowth, disruption of the gut-brain axis, and the sheer physical distress that constipation causes — distress that a person with dementia may express through agitation, aggression, or withdrawal rather than words. There’s also a medication feedback loop that caregivers should understand. Many drugs commonly prescribed for dementia symptoms — including anticholinergics for bladder urgency, certain antidepressants, and opioid pain medications — cause constipation as a side effect.
The constipation gets treated with a stimulant laxative, which eventually stops working well, which leads to fecal impaction, which leads to overflow diarrhea that gets mistaken for a stomach bug or a new problem entirely. In memory care facilities, this misdiagnosis cycle is disturbingly common. However, if the person is on an opioid for chronic pain — which is the case for a significant minority of dementia patients — the constipation is driven by opioid receptors in the gut, not by motility issues alone. In that specific situation, a standard osmotic laxative may not be sufficient, and a peripherally acting mu-opioid receptor antagonist like methylnaltrexone (Relistor) may be the appropriate tool. This is a case where the solution depends entirely on the cause, and a blanket recommendation to “just use MiraLAX” could leave the person suffering.
